The growth of the hydantoin anticonvulsants market is being driven by an increase in research and development activities within the pharmaceutical sector. This trend is expected to significantly benefit the market\'s expansion. Additionally, the rising rate of drug approvals and new product launches is likely to further accelerate market growth. Hydantoins are a class of pharmaceuticals widely utilized for the treatment of seizures, functioning as anticonvulsant or antiepileptic drugs. They operate by blocking sodium channels, which are prevalent throughout the nervous system.